Letrozole Superior To Tamoxifen In Breast Cancer

Links shared publicly online about this topic.

  • 1,507
    total visits

Letrozole Superior To Tamoxifen In Breast Cancer

medicalnewstoday.com

The aromatase inhibitor letrozole (femara) produces a significant survival benefit over tamoxifen when used as adjuvant therapy for postmenopausal women with endocrine-responsive breast cancer, a

View full resource at medicalnewstoday.com

Tags: Cancer, Breast Cancer, Breast Cancer Medication, Women's Health, Femara

  • Share

Most Recently Shared on December 24, 2009 at 12:14 pm By:

mnt_healthnews MNT Health News

#health_news Letrozole Superior To Tamoxifen In Breast Cancer: The aromatase inhibitor letrozole (F.. http://bit.ly/938bBx

2 years ago...

Oncology Medical Article | Bone effect of adjuvant tamoxifen, letrozole or letrozole plus zoledronic acid in early-stage breast cancer

mdlinx.com — “Oncology Medical Article: Bone effect of adjuvant tamoxifen, letrozole or letrozole plus zoledronic acid in early-stage breast cancerView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on March 14, 2012 at 7:36 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Bone effect of adjuvant tamoxifen, letrozole or letrozole plus zoledronic acid in early-stage breast c... http://t.co/1vtehUEb #oncology

2 months ago...

NCI Cancer Bulletin for November 1, 2011 - National Cancer Institute

cancer.gov — “NCI Cancer Bulletin for November 1, 2011 - National Cancer InstituteView full resource at cancer.gov

  • View Related
  • Share

Most Recently Shared on November 2, 2011 at 1:33 pm By:

NCIBulletin NCI Cancer Bulletin Health News

Annual screening with chest x-ray does not reduce lung cancer deaths http://t.co/uXEj5DBp

6 months ago...

Letrozole Surpasses Tamoxifen at Reducing Breast Cancer Recurrence - NYTimes.com

nytimes.com — “The drug letrozole reduces the chances that a woman’s breast cancer will return and improves her odds of survival to a greater degree than tamoxifen, a study shows.View full resource at nytimes.com

  • View Related
  • Share

Most Recently Shared on October 24, 2011 at 5:38 pm By:

HealthTrendster HealthTrendster Health Executive

Vital Signs: Letrozole Surpasses Tamoxifen at Reducing Breast Cancer Recurrence http://t.co/A63GfCwG

6 months ago...

Breast Cancer Survival: Femara Better Than Tamoxifen

webmd.com — “Older women with early breast cancers have fewer recurrences and significantly longer survival times when they take the aromatase inhibitor Femara (letrozole) instead of tamoxifen, a long-term follow-up study shows.View full resource at webmd.com

  • View Related
  • Share

Most Recently Shared on October 21, 2011 at 8:58 pm By:

knoxvillehosp Knoxville Hospital Hospital

Breast Cancer Survival: Femara Better Than Tamoxifen: Older women with early breast cancers have fewer recurrenc... http://t.co/Wkw0t9jr

6 months ago...

Study confirms tamoxifen is superior to fulvestrant in blocking estrogen

news-medical.net — “For the first time, researchers at Seattle Cancer Care Alliance have demonstrated the feasibility of using serial positron emission tomography (PET) scans, using a special estrogen-containing isotope, to confirm the relative effectiveness of estrogen-blocking and estrogen-depleting therapy in patients with metastatic breast cancer.View full resource at news-medical.net

  • View Related
  • Share

Most Recently Shared on August 19, 2011 at 12:56 pm By:

NewsMedical News-Medical.Net Health News

Study confirms tamoxifen is superior to fulvestrant in blocking estrogen: For the first time, researchers at Sea... http://t.co/4vHE2zs

8 months ago...

BIG 1-98: Adjuvant letrozole reduced risk for death, recurrence compared with tamoxifen | HemOncToday

hemonctoday.com — “Further analysis from the phase 3 BIG 1-98 trial showed that women with breast cancer assigned to letrozole had superior 5-year OS and were lView full resource at hemonctoday.com

  • View Related
  • Share

Most Recently Shared on March 14, 2011 at 2:11 pm By:

HemOncToday HemOnc Today Oncology and Health News

BIG 1-98: Adjuvant letrozole reduced risk for death, recurrence compared with tamoxifen http://bit.ly/gbXJAl

1 year ago...

Long-term ATAC results confirm superior efficacy, safety of anastrozole vs. tamoxifen for early breast cancer | HemOncToday

hemonctoday.com — “The 10-year follow-up results of the ATAC trial have confirmed the superior efficacy and safety of the aromatase inhibitor anastrozole comparView full resource at hemonctoday.com

  • View Related
  • Share

Most Recently Shared on November 29, 2010 at 9:23 pm By:

HemOncToday HemOnc Today Oncology and Health News

Long-term ATAC results confirm superior efficacy, safety of anastrozole vs. tamoxifen for early breast cancer http://bit.ly/hztbGk

1 year ago...

Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial : The Lancet Oncology

thelancet.com — “Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. By - Prof Jack Cuzick PhD, Ivana Sestak PhD, Prof Michael Baum MD, Prof ...View full resource at thelancet.com

  • View Related
  • Share

Most Recently Shared on November 29, 2010 at 6:24 pm By:

Oncology Medical News about Breast Neoplasms Postmenopause Tamoxifen Chemotherapy, Adjuvant

mdlinx.com — “Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in the BIG 1-98 randomized trialView full resource at mdlinx.com

  • View Related
  • Share

Most Recently Shared on April 14, 2010 at 9:17 am By:

MDLinx Sandeep Pulim MD Doctor, Health Communicator, and Physician

Cognitive function in postmenopausal women receiving adjuvant letrozole or tamoxifen for breast cancer in... http://bit.ly/bvUF4E #oncology

2 years ago...

BIG 1-98: Benefits of letrozole over tamoxifen greater than previously reported | HemOncToday

hemonctoday.com — “San Antonio Breast Cancer Symposium</PView full resource at hemonctoday.com

  • View Related
  • Share

Most Recently Shared on December 14, 2009 at 2:18 pm By:

HemOncToday HemOnc Today Oncology and Health News

#SABCS BIG 1-98: Benefits of letrozole over tamoxifen greater than previously reported http://ow.ly/LT9z

2 years ago...

NEJM -- Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast Cancer

content.nejm.org — “Original Article from The New England Journal of Medicine -- Letrozole Therapy Alone or in Sequence with Tamoxifen in Women with Breast CancerView full resource at content.nejm.org

  • View Related
  • Share

Most Recently Shared on August 20, 2009 at 6:14 pm By:

HemOncToday HemOnc Today Oncology and Health News

BIG 1-98 data, originally presented at SABCS http://ow.ly/kKjl, published today in #NEJM: letrozole superior to tamoxifen http://ow.ly/kKkj

3 years ago...

Medical News: Sequential Strategy No Help in Early Breast Cancer - in Hematology/Oncology, Breast Cancer from MedPage Today

medpagetoday.com — “For postmenopausal women with endocrine-responsive early breast cancer, a sequence of letrozole (Femara) and tamoxifen holds no advantage over letrozole alone, although it may be better than tamoxifenView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on August 19, 2009 at 11:36 pm By:

MedicalNews Medical News Health News

Sequential Strategy No Help in Early Breast Cancer (CME/CE) http://ow.ly/15LFtb

3 years ago...

Newer Drug Beats Tamoxifen for Older Breast Cancer Patients - Drugs.com MedNews

drugs.com — “For postmenopausal women with breast cancer, treatment with the drug letrozole (Femara) increases survival after surgery more than the widely used tamoxifen, a View full resource at drugs.com

  • View Related
  • Share

Most Recently Shared on August 19, 2009 at 10:48 pm By:

drugscom Drugs.com Health Site

Newer Drug Beats Tamoxifen for Older Breast Cancer Patients - http://bit.ly/F9isS

3 years ago...

Health Articles, Tips & News | Newer Drug Beats Tamoxifen for Older Breast Cancer Patients (HealthDay)

healtharticles.ws — “HealthDay - WEDNESDAY, Aug. 19 (HealthDay News) -- For postmenopausal women with breast cancer, treatment with the drug letrozole (Femara) increases survival after surgery more than the widely used tamoxifen, a new study confirms.View full resource at healtharticles.ws

  • View Related
  • Share

Most Recently Shared on August 19, 2009 at 9:39 pm By:

RNconsult Patricia A. Jackson Nurse

@health_articles Newer Drug Beats Tamoxifen for Older Breast Cancer Patients (HealthDay) http://bit.ly/19w2cP

3 years ago...

Advertisement